Amcor Other Income (Expense) increased by 100.0% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 300.0%, from -$1.00M to $2.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 2.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $5.00M | $2.00M | $5.00M | $0.00 | $0.00 | $3.00M | $2.00M | -$1.00M | $1.00M | $2.00M | $1.00M | -$1.00M | -$1.00M | -$1.00M | -$9.00M | $1.00M | $1.00M | $2.00M |
| QoQ Change | — | +25.0% | -60.0% | +150.0% | -100.0% | — | — | -33.3% | -150.0% | +200.0% | +100.0% | -50.0% | -200.0% | +0.0% | +0.0% | -800.0% | +111.1% | +0.0% | +100.0% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | +50.0% | -60.0% | — | -66.7% | +0.0% | — | +0.0% | -200.0% | -150.0% | <-999% | +200.0% | +200.0% | +300.0% |